Bioreactor Technologies (Technologies): A Comparison of Manufacturing Efficiency and the Impact on Pricing Standard Protocols for US Albumin Market Share.
The potential entry of biosimilars or generic versions of albumin (often Non-Plasma-Derived Alternatives (Product types)) is a defining factor in the ongoing US Albumin Market analysis. While plasma-derived albumin is regulated differently than typical biologics, the advent of recombinant Technologies has opened the door for bioequivalent Product Types. This competitive...
0 Комментарии 0 Поделились 433 Просмотры 0 предпросмотр